PT - JOURNAL ARTICLE AU - Masafumi Hagiwara AU - Satomi Adachi-Akahane AU - Taku Nagao TI - High-Affinity Binding of DTZ323, a Novel Derivative of Diltiazem, to Rabbit Skeletal Muscle L-type Ca<sup>++</sup> Channels DP - 1997 Apr 01 TA - Journal of Pharmacology and Experimental Therapeutics PG - 173--179 VI - 281 IP - 1 4099 - http://jpet.aspetjournals.org/content/281/1/173.short 4100 - http://jpet.aspetjournals.org/content/281/1/173.full SO - J Pharmacol Exp Ther1997 Apr 01; 281 AB - A novel derivative of diltiazem (1,5-benzothiazepine Ca++ antagonist), DTZ323, 3-(acetyloxy)-5-[2-[[2-(3,4-dimethoxyphenyl)ethyl]-methylamino]ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepine-4(5H)-one, was characterized by radioligand binding experiments with rabbit skeletal T-tubule membranes in terms of the affinity and the selectivity to the binding sites for the three classical calcium antagonists, such as dihydropyridines, phenylalkylamines and benzothiazepines. DTZ323, like diltiazem and clentiazem, exhibited complete and concentration-dependent inhibition ofd-cis-[3H]diltiazem binding to the membrane with a slope factor close to unity.K i values indicated that DTZ323 (K i = 6.6 ± 0.6 nM, mean ± S.E.,n = 4) was 48 times and 9 times more potent than diltiazem and clentiazem, respectively. DTZ323 partially inhibited the specific binding of a dihydropyridine ligand, (+)-[3H]PN200–110, at 37°C. The equilibrium saturation study showed that DTZ323 reduces the affinity for the (+)-[3H]PN200–110 binding in a concentration-dependent manner with a slight decrease in the density of the binding sites. DTZ323 also inhibited the specific binding of a phenylalkylamine ligand, (−)-[3H]D888, completely as did diltiazem. DTZ323 (1 μM) had no effect on the dissociation rate ofd-cis-[3H]diltiazem at 2°C, whereas 30 μM verapamil increased the dissociation rate, which suggested that DTZ323 inhibits the specific binding ofd-cis-[3H]diltiazem in a manner similar to other competitive ligands for the benzothiazepine binding site. These results indicate that DTZ323 is a selective ligand for the 1,5-benzothiazepine binding site with the highest affinity among the diltiazem derivatives. The American Society for Pharmacology and Experimental Therapeutics